Literature DB >> 11379495

Malaria in the Australian Defence Force during and after participation in the International Force in East Timor (INTERFET).

S J Kitchener1, A M Auliff, K H Rieckmann.   

Abstract

Malaria in Australian Defence Force members has been far more common in East Timor than in other recent overseas deployments. By six months after all 5,500 members of the International Force in East Timor had returned to Australia, 267 malaria infections had been reported to the Army Malaria Institute. Only 64 of those affected had their first clinical episode during their 4-5 months in East Timor, and about two-thirds of these infections were caused by Plasmodium falciparum. The remaining 212 soldiers developed their first symptoms after returning to Australia, and all but two infections were caused by P. vivax. After treatment, 44 soldiers had relapses of their vivax infections; 11 had a second relapse and two had a third relapse. These findings raise several issues about prevention and management of malaria in the ADF.

Entities:  

Mesh:

Year:  2000        PMID: 11379495     DOI: 10.5694/j.1326-5377.2000.tb139349.x

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


  5 in total

1.  Randomized, double-blind study of the safety, tolerability, and efficacy of tafenoquine versus mefloquine for malaria prophylaxis in nonimmune subjects.

Authors:  Peter E Nasveld; Michael D Edstein; Mark Reid; Leonard Brennan; Ivor E Harris; Scott J Kitchener; Peter A Leggat; Philip Pickford; Caron Kerr; Colin Ohrt; William Prescott
Journal:  Antimicrob Agents Chemother       Date:  2009-12-07       Impact factor: 5.191

2.  Defining the role of mutations in Plasmodium vivax dihydrofolate reductase-thymidylate synthase gene using an episomal Plasmodium falciparum transfection system.

Authors:  Alyson M Auliff; John H Adams; Michael T O'Neil; Qin Cheng
Journal:  Antimicrob Agents Chemother       Date:  2010-06-21       Impact factor: 5.191

3.  Malaria vectors of Timor-Leste.

Authors:  Robert D Cooper; Michael D Edstein; Stephen P Frances; Nigel W Beebe
Journal:  Malar J       Date:  2010-02-02       Impact factor: 2.979

4.  Directly-observed therapy (DOT) for the radical 14-day primaquine treatment of Plasmodium vivax malaria on the Thai-Myanmar border.

Authors:  Rie Takeuchi; Saranath Lawpoolsri; Mallika Imwong; Jun Kobayashi; Jaranit Kaewkungwal; Sasithon Pukrittayakamee; Supalap Puangsa-art; Nipon Thanyavanich; Wanchai Maneeboonyang; Nicholas P J Day; Pratap Singhasivanon
Journal:  Malar J       Date:  2010-11-01       Impact factor: 2.979

5.  A retrospective analysis of the protective efficacy of tafenoquine and mefloquine as prophylactic anti-malarials in non-immune individuals during deployment to a malaria-endemic area.

Authors:  Geoffrey S Dow; William F McCarthy; Mark Reid; Bryan Smith; Douglas Tang; G Dennis Shanks
Journal:  Malar J       Date:  2014-02-06       Impact factor: 2.979

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.